AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19731245 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted gastrectomy (LAG)
Number of subjects: 106
Study 19731330 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea (20 mg/kg/day for 2 years)
Number of subjects: 200
Study 19731330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 19734762 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ocular features (drusen size, focal hyperpigmentation, nonfoveal geographic atrophy)
Number of subjects: 370
Study 19734762 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up angiograms
Number of subjects: 370
Study 19734762 — intervention group
Group type: COMPARATOR
Intervention: Nonocular characteristics (age, gender, history of hypertension, smoking)
Number of subjects: 370
Study 19734762 — intervention group
Group type: COMPARATOR
Intervention: Ocular features of the study eye at baseline (lesion composition, lesion size, visual acuity)
Number of subjects: 370
Study 19738014 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ganciclovir at 5 mg/kg of body weight for 5 days, followed by oral valganciclovir at 900 mg for 16 days, both twice daily with dose adjustment for renal function.
Number of subjects: 382
Study 19738136 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecarfarin (ATI-5923)
Number of subjects: 66
Study 19738136 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 66
Study 19738484 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infected individuals
Number of subjects: 922
Study 19738484 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infected individuals with CD4 < 200
Number of subjects: 922
Study 19738484 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infected individuals with CD4 200-350
Number of subjects: 922
Study 19738484 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infected individuals with CD4 > 350
Number of subjects: 922
Study 19738484 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infected individuals (current smokers)
Number of subjects: 922
Study 19738484 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infected individuals (older age)
Number of subjects: 922
Study 19738484 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV infected individuals (baseline CD4 count)
Number of subjects: 922
Study 19738484 — intervention group
Group type: COMPARATOR
Intervention: HIV infected individuals compared to controls
Number of subjects: 922
Study 19740906 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumour necrosis factor alpha inhibitors (TNFalpha) - infliximab (n=41), etanercept (n=13), adalimumab (n=6)
Number of subjects: 60
Study 19740906 — intervention group
Group type: EXPERIMENTAL
Intervention: BASDAI
Number of subjects: 60
Study 19740906 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 60
Study 19740906 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in BASDAI
Number of subjects: 60
Study 19740972 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese adults
Number of subjects: 36
Study 19740972 — intervention group
Group type: COMPARATOR
Intervention: Normal-weight adults
Number of subjects: 36
Study 19741187 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced diabetes care program addressing literacy and numeracy
Number of subjects: 198
Study 19741187 — intervention group
Group type: COMPARATOR
Intervention: Existing enhanced diabetes care programs
Number of subjects: 198
Study 19741187 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 198
Study 19741558 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic convergence insufficiency with parent report of ADHD
Number of subjects: 261
Study 19741558 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic convergence insufficiency with parent report of no ADHD
Number of subjects: 261
Study 19741558 — intervention group
Group type: COMPARATOR
Intervention: Normal binocular vision (NBV)
Number of subjects: 261
Study 19744339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-initiated intervention, which couples low-intensity inpatient counseling with sustained proactive telephone counseling.
Number of subjects: 0
Study 19744339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse training in delivery of bedside cessation counseling, electronic medical record tools, computerized referral for proactive telephone counseling, and use of internal nursing facilitators.
Number of subjects: 0
Study 19744339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-initiated intervention.
Number of subjects: 0
Study 19745067 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentostatin
Number of subjects: 51
Study 19747748 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucose variability
Number of subjects: 0
Study 19750065 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Decision Support System (CDSS) for MDD treatment
Number of subjects: 55
Study 19750065 — intervention group
Group type: COMPARATOR
Intervention: Usual care for MDD treatment
Number of subjects: 55
Study 19751237 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (4 weekly doses)
Number of subjects: 69
Study 19751237 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor response (25-50% IgM reduction)
Number of subjects: 69
Study 19752173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention trial (specific intervention details not provided)
Number of subjects: 664
Study 19752173 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 664
Study 19752422 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals of African descent
Number of subjects: 1221
Study 19752422 — intervention group
Group type: COMPARATOR
Intervention: Individuals of European descent
Number of subjects: 1221
Study 19752530 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated uric acid group (>6 mg/dl)
Number of subjects: 58
Study 19752530 — intervention group
Group type: COMPARATOR
Intervention: Normal uric acid group (≤6 mg/dl)
Number of subjects: 58
Study 19752530 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated preoperative uric acid
Number of subjects: 58
Study 19753491 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypanocidal treatment with benznidazole
Number of subjects: 0
Study 19753491 — intervention group
Group type: EXPERIMENTAL
Intervention: Antitrypanosomal therapy with benznidazole
Number of subjects: 0
Study 19753491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19754502 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 258
Study 19754502 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 258
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart transplantation referral
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilated cardiomyopathy
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: NYHA class IV
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery systolic pressure ≥50 mmHg
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary capillary pressure ≥25 mmHg
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction ≤17%
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional NYHA class IV
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic systolic arterial pressure ≤90 mmHg
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: hsCRP≥6.5 mg/L
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: NTpro-BNP≥4302 pg/mL
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Na serum level≤135 mEq/L
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI≤23.8
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: HFSS≤7.19
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium plasma levels ≤135 mEq/L
Number of subjects: 983
Study 19755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium plasma levels ≤135 mEq/L + NTpro-BNP≥4302 pg/mL
Number of subjects: 983
Study 19755366 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoring system for authorship based on contributions to the study
Number of subjects: 0
Study 19755674 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 5% residual normal plasma cells (N-PCs/BMPCs)
Number of subjects: 594
Study 19755674 — intervention group
Group type: COMPARATOR
Intervention: Less than or equal to 5% residual normal plasma cells (N-PCs/BMPCs)
Number of subjects: 594
Study 19757984 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-bronchodilator FEV(1)/FVC ratio < or = 0.70
Number of subjects: 100
Study 19757984 — intervention group
Group type: COMPARATOR
Intervention: Post-bronchodilator FEV(1)/FVC ratio > 0.70
Number of subjects: 100
Study 19757984 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported dyspnea
Number of subjects: 100
Study 19757984 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion with doctor about cough
Number of subjects: 100
Study 19758095 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe water storage vessels, hygiene education, and bleach for household water treatment (Cohort B)
Number of subjects: 0
Study 19758095 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Cohort A)
Number of subjects: 0
Study 19760233 — intervention group
Group type: EXPERIMENTAL
Intervention: CT imaging in patients with >or=1 positive predictors (855 patients)
Number of subjects: 1047
Study 19760233 — intervention group
Group type: COMPARATOR
Intervention: No CT imaging in patients with no positive predictors (192 patients)
Number of subjects: 1047
Study 19760338 — intervention group
Group type: EXPERIMENTAL
Intervention: PET
Number of subjects: 3019
Study 19760338 — intervention group
Group type: EXPERIMENTAL
Intervention: CTA
Number of subjects: 3019
Study 19760338 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT
Number of subjects: 3019
Study 19760338 — intervention group
Group type: EXPERIMENTAL
Intervention: All imaging arms (PET, CTA, SPECT)
Number of subjects: 3019
Study 19766264 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children (Ob)
Number of subjects: 52
Study 19766264 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children (Ob) after 500-kcal liquid meal
Number of subjects: 52
Study 19766264 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children (Ob) after 1-year lifestyle intervention
Number of subjects: 52
Study 19766264 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight status changes in Obese children (Ob)
Number of subjects: 52
Study 19766264 — intervention group
Group type: COMPARATOR
Intervention: Craniopharyngioma patients (CP)
Number of subjects: 52
Study 19766264 — intervention group
Group type: COMPARATOR
Intervention: MC4Rmut patients
Number of subjects: 52
Study 19767508 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim PET scans reviewed by expert panel
Number of subjects: 38
Study 19769536 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin plus artesunate (AZ+AS)
Number of subjects: 261
Study 19769536 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 261
Study 19770418 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and perioperative INGN 201 gene therapy
Number of subjects: 13
Study 19771175 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP rs3822086
Number of subjects: 239
Study 19771175 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP rs3775444
Number of subjects: 239
Study 19771175 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-SNP haplotype including rs3822086
Number of subjects: 239
Study 19771508 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin and docetaxel (2 or 3 weekly intervals)
Number of subjects: 50
Study 19771508 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment tumor cellularity
Number of subjects: 50
Study 19771508 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline PR levels
Number of subjects: 50
Study 19773266 — intervention group
Group type: EXPERIMENTAL
Intervention: CD20 positivity over 20%
Number of subjects: 143
Study 19773266 — intervention group
Group type: EXPERIMENTAL
Intervention: CD20 positivity over 20% in patients with WBC over 30x10(9)/L
Number of subjects: 143
Study 19773371 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib 400 mg b.i.d.
Number of subjects: 31
Study 19773418 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapamycin
Number of subjects: 0
Study 19773418 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 19775921 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGAA (recombinant human GAA) at a cumulative dose of 20 or 40 mg/kg/2 weeks
Number of subjects: 32
Study 19775921 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGAA (recombinant human GAA)
Number of subjects: 32
Study 19776145 — intervention group
Group type: EXPERIMENTAL
Intervention: Total osteocalcin
Number of subjects: 348
Study 19776145 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxylated osteocalcin
Number of subjects: 348
Study 19776145 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncarboxylated osteocalcin
Number of subjects: 348
Study 19779040 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasatinib treatment
Number of subjects: 1043
Study 19780691 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine case management intervention
Number of subjects: 10
Study 19780860 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-B*5701 assessment
Number of subjects: 1494
Study 19782361 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10mg per day for one year
Number of subjects: 19
Study 19782922 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary angiography
Number of subjects: 54
Study 19783666 — intervention group
Group type: EXPERIMENTAL
Intervention: Population participants without CVD
Number of subjects: 621
Study 19783666 — intervention group
Group type: EXPERIMENTAL
Intervention: Population participants with CVD
Number of subjects: 621
Study 19783666 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital patients with CAD
Number of subjects: 621
Study 19783666 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups with spirometrically confirmed AL
Number of subjects: 621
Study 19786468 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (enoxaparin or nadroparin)
Number of subjects: 320
Study 19786468 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-type hypersensitivity reactions
Number of subjects: 320
Study 19786468 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index greater than 25
Number of subjects: 320
Study 19786468 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of heparin therapy longer than 9 days
Number of subjects: 320
Study 19786468 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 320
Study 19786617 — intervention group
Group type: EXPERIMENTAL
Intervention: (131)I-BC8 antibody (Ab; BC8) plus fludarabine and 2 Gy total body irradiation
Number of subjects: 58
Study 19786667 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide 15 mg/d plus bortezomib 1.0 mg/m(2)
Number of subjects: 38
Study 19786667 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide plus bortezomib
Number of subjects: 38
Study 19786667 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone added for progressive disease
Number of subjects: 38
Study 19786667 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 38
Study 19786927 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafilcon A lenses for monthly continuous wear (CW)
Number of subjects: 205
Study 19788468 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan
Number of subjects: 0
Study 19788755 — intervention group
Group type: EXPERIMENTAL
Intervention: Community care coordinators (CCCs) providing care every three months in clinics and monthly in the community; CCCs underwent intensive training and mentoring.
Number of subjects: 190
Study 19788755 — intervention group
Group type: COMPARATOR
Intervention: Standard of care with monthly clinic visits.
Number of subjects: 190
Study 19789316 — intervention group
Group type: EXPERIMENTAL
Intervention: SGN-30 (4 mg/kg to 12 mg/kg, i.v. every 3 weeks for six doses, with potential for two additional courses)
Number of subjects: 23
Study 19789316 — intervention group
Group type: EXPERIMENTAL
Intervention: SGN-30
Number of subjects: 23
Study 19793395 — intervention group
Group type: EXPERIMENTAL
Intervention: AUDS group
Number of subjects: 32
Study 19793395 — intervention group
Group type: COMPARATOR
Intervention: MDE group
Number of subjects: 32
Study 19793856 — intervention group
Group type: COMPARATOR
Intervention: Acute weight restoration in AN patients
Number of subjects: 30
Study 19793856 — intervention group
Group type: COMPARATOR
Intervention: 1-year weight maintenance in AN patients
Number of subjects: 30
Study 19796970 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cross-sectional area (CSA) of small pulmonary vessels < 5 mm²
Number of subjects: 191
Study 19796970 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cross-sectional area (CSA) of small pulmonary vessels 5-10 mm²
Number of subjects: 191
Study 19796996 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral endoscopic restrictive implant system
Number of subjects: 0
Study 19797219 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity assessment using ETDRS charts
Number of subjects: 78
Study 19797219 — intervention group
Group type: EXPERIMENTAL
Intervention: GA size quantified in digital fundus autofluorescence images
Number of subjects: 78
Study 19797219 — intervention group
Group type: EXPERIMENTAL
Intervention: GA progression rate assessment
Number of subjects: 78
Study 19797518 — intervention group
Group type: EXPERIMENTAL
Intervention: Interphase fluorescence in situ hybridization (I-FISH) with cutoff value of less than 1% positive nuclei.
Number of subjects: 664
Study 19797518 — intervention group
Group type: COMPARATOR
Intervention: Chromosome banding analysis (CBA)
Number of subjects: 664
Study 19797518 — intervention group
Group type: EXPERIMENTAL
Intervention: I-FISH with less than 1% positive nuclei
Number of subjects: 664
Study 19797518 — intervention group
Group type: COMPARATOR
Intervention: I-FISH with 1% to 5% positive nuclei
Number of subjects: 664
Study 19797518 — intervention group
Group type: EXPERIMENTAL
Intervention: CCgR with I-FISH less than 1%
Number of subjects: 664
Study 19797518 — intervention group
Group type: COMPARATOR
Intervention: CCgR with I-FISH 1% to 5%
Number of subjects: 664
Study 19797573 — intervention group
Group type: EXPERIMENTAL
Intervention: Provocative landing position
Number of subjects: 25
Study 19797573 — intervention group
Group type: EXPERIMENTAL
Intervention: Exaggerated provocative landing position
Number of subjects: 25
Study 19797573 — intervention group
Group type: COMPARATOR
Intervention: Safe landing position
Number of subjects: 25
Study 19799842 — intervention group
Group type: EXPERIMENTAL
Intervention: S. aureus conjugate vaccine (StaphVAX) comprised of capsular polysaccharides 5 and 8 (CP5, CP8)
Number of subjects: 88
Study 19799842 — intervention group
Group type: EXPERIMENTAL
Intervention: S. aureus conjugate vaccine (StaphVAX)
Number of subjects: 88
Study 19801505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac T2* magnetic resonance <10 ms
Number of subjects: 652
Study 19801505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac T2* magnetic resonance <20 ms
Number of subjects: 652
Study 19801505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac T2* magnetic resonance
Number of subjects: 652
Study 19801583 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean patients with OSA
Number of subjects: 54
Study 19801583 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 54
Study 19801583 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study 19802379 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive patient groups
Number of subjects: 0
Study 19802379 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs)
Number of subjects: 0
Study 19802379 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management
Number of subjects: 0
Study 19802379 — intervention group
Group type: EXPERIMENTAL
Intervention: Widespread implementation of CHWs
Number of subjects: 0
Study 19802383 — intervention group
Group type: EXPERIMENTAL
Intervention: As+SMP
Number of subjects: 800
Study 19802383 — intervention group
Group type: COMPARATOR
Intervention: PZQ
Number of subjects: 800
Study 19805455 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuPH20-facilitated subcutaneous rehydration
Number of subjects: 51
Study 19805597 — intervention group
Group type: EXPERIMENTAL
Intervention: HOME Injury Survey
Number of subjects: 163
Study 19806596 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib as adjuvant treatment
Number of subjects: 0
Study 19808143 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal system (MTS)
Number of subjects: 327
Study 19808270 — intervention group
Group type: EXPERIMENTAL
Intervention: Day of admission (weekdays vs. weekends)
Number of subjects: 48612
Study 19808270 — intervention group
Group type: EXPERIMENTAL
Intervention: Thursday and Friday admissions
Number of subjects: 48612
Study 19808511 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortex of blood flow in the main pulmonary artery
Number of subjects: 48
Study 19808511 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortex criterion diagnostic performance
Number of subjects: 48
Study 19808511 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of vortex existence period with mean pulmonary arterial pressure
Number of subjects: 48
Study 19808511 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of catheter-derived mean pulmonary artery pressure and calculated mean pulmonary artery pressure
Number of subjects: 48
Study 19808512 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct en face velocity-encoded cardiovascular magnetic resonance (veCMR)
Number of subjects: 44
Study 19808512 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct en face veCMR
Number of subjects: 44